Figure 2From: Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma Kaplan-Meier curves of the four treatment arms: overall survival (upper panel) and progression-free survival (lower panel). Back to article page